Vrablík M - Search Results

1

Rare variants in known and novel candidate genes predisposing to statin-associated myopathy.

Neřoldová M, Stránecký V, Hodaňová K, Hartmannová H, Piherová L, Přistoupilová A, Mrázová L, Vrablík M, Adámková V, Hubáček JA, Jirsa M, Kmoch S. Neřoldová M, et al. Among authors: vrablik m. Pharmacogenomics. 2016 Aug;17(13):1405-14. doi: 10.2217/pgs-2016-0071. Epub 2016 Jun 14. Pharmacogenomics. 2016. PMID: 27296017

2

Ser19-->Trp polymorphism within the apolipoprotein AV gene in hypertriglyceridaemic people.

Vrablík M, Horínek A, Ceska R, Adámková V, Poledne R, Hubacek JA. Vrablík M, et al. J Med Genet. 2003 Aug;40(8):e105. doi: 10.1136/jmg.40.8.e105. J Med Genet. 2003. PMID: 12920097 Free PMC article. No abstract available.

3

New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels.

Hubácek JA, Adámková V, Ceska R, Poledne R, Horínek A, Vráblík M. Hubácek JA, et al. Among authors: vrablik m. Physiol Res. 2004;53(2):225-8. Physiol Res. 2004. PMID: 15046561 Free article.

4

Hypertriglyceridemia: interaction between APOE and APOAV variants.

Hubacek JA, Horínek A, Skodova Z, Adamkova V, Ceska R, Zlatohlavek L, Vráblík M. Hubacek JA, et al. Among authors: vrablik m. Clin Chem. 2005 Jul;51(7):1311-3. doi: 10.1373/clinchem.2005.048439. Clin Chem. 2005. PMID: 15976129 No abstract available.

5

[Genetics of dyslipidemia--yesterday, today, and tomorrow].

Hubácek JA, Vrablík M. Hubácek JA, et al. Among authors: vrablik m. Vnitr Lek. 2007 Apr;53(4):371-6. Vnitr Lek. 2007. PMID: 17578168 Review. Czech.

6

[Statin pharmacokinetics].

Hubácek JA, Adámková V, Zídková K, Ceska R, Zlatohlávek L, Stulc T, Horínek A, Vrablík M. Hubácek JA, et al. Among authors: vrablik m. Vnitr Lek. 2008 Jan;54(1):62-7. Vnitr Lek. 2008. PMID: 18390119 Review. Czech.

7

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels.

Hubacek JA, Wang WW, Skodová Z, Adámková V, Vráblík M, Horínek A, Stulc T, Ceska R, Talmud PJ. Hubacek JA, et al. Among authors: vrablik m. Clin Chem Lab Med. 2008;46(6):773-7. doi: 10.1515/CCLM.2008.160. Clin Chem Lab Med. 2008. PMID: 18601597

8

MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe.

Vrablik M, Ceska R, Adamkova V, Peasey A, Pikhart H, Kubinova R, Marmot M, Bobak M, Hubacek JA. Vrablik M, et al. Hum Genet. 2008 Dec;124(5):553-5. doi: 10.1007/s00439-008-0577-6. Epub 2008 Oct 23. Hum Genet. 2008. PMID: 18946681

9

Impact of apolipoprotein A5 variants on statin treatment efficacy.

Hubacek JA, Adamkova V, Prusikova M, Snejdrlova M, Hirschfeldova K, Lanska V, Ceska R, Vrablik M. Hubacek JA, et al. Among authors: vrablik m. Pharmacogenomics. 2009 Jun;10(6):945-50. doi: 10.2217/pgs.09.17. Pharmacogenomics. 2009. PMID: 19530961

10

Apolipoprotein AV gene polymorphisms (T-1131/C and Ser19/Trp) influence plasma triglyceride levels and risk of myocardial infarction.

Hubacek JA, Skodova Z, Adamkova V, Vrablik M, Horinek A, Lanska V, Ceska R, Poledne R. Hubacek JA, et al. Among authors: vrablik m. Exp Clin Cardiol. 2003 Fall;8(3):151-4. Exp Clin Cardiol. 2003. PMID: 19641709 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page